Related references
Note: Only part of the references are listed.Carcinoma in situ of the Urinary Bladder: Review of Clinicopathologic Characteristics with an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis
Nalan Nese et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria
Kogenta Nakamura et al.
BMC Urology (2009)
USEFULNESS OF URINE CYTOLOGY FOR BLADDER CARCINOMA DIAGNOSIS: COMPARATIVE STUDY WITH BIOPSY
Castro M. A. Garcia et al.
ACTAS UROLOGICAS ESPANOLAS (2008)
Long-term outcome of home dipstick testing for hematuria
Ralph Madeb et al.
WORLD JOURNAL OF UROLOGY (2008)
Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer
A Kumar et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
HB Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Is cytology required for a hematuria evaluation?
CA Hofland et al.
JOURNAL OF UROLOGY (2004)
Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis
MP Raitanen et al.
EUROPEAN UROLOGY (2002)
Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up
GD Grossfeld et al.
UROLOGY (2001)
Urine cytology - Is it still the gold standard for screening?
FM Brown
UROLOGIC CLINICS OF NORTH AMERICA (2000)
Share Paper
